How not to publicize medical research in the age of overhype

In a publishing climate polluted with nonstop noise, irresistible clickbait and non-newsworthy nonsense, it can be tempting for researchers as well as reporters to subtly sensationalize findings and conclusions from clinical studies.

Or, as put by researcher Steven Salzberg, PhD, of Johns Hopkins:

“Journalists and scientists need to work harder to come up with headlines that excite people about the potential of science without making it seem that we’ve already cured humankind’s most devastating diseases.”

Salzberg says more and gives some recent examples in a March 7 Forbes post: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.